UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Medytox’ botulinum toxin may face approval delay in China
by Jeong Sae-im
2019-06-10 13:55
State health insurance agency, WHO seeks cooperation
by Kim Eun-young
2019-06-07 16:27
Kolon TissueGene CEO resigns
by Jeong Sae-im
2019-06-07 15:35
Expat workers left behind in mandatory health insurance program
by Kim Eun-young
2019-06-07 15:27
Patient Revolution author admits license revocation on Facebook
by Song Soo-youn
2019-06-07 14:58
라인
Daewoong joins fray to develop rheumatoid arthritis drug
by Lee Hye-seon
2019-06-07 11:29
Ilsan Hospital succeeds in single-port retroperitoneal renal tumor resection
by Song Soo-youn
2019-06-05 16:14
Korea’s hospital information system launched at 4th US hospital
by Choi Gwang-seok
2019-06-05 14:59
Pharma industry urges deregulation to develop new drug using AI
by Jeong Sae-im
2019-06-05 11:53
[ASCO 2019] 'Ibrance brings hopes to neglected premenopausal breast cancer patients'
by Lee Han-soo, KBR Corresponden
2019-06-05 11:33
라인
[ASCO 2019]'Belvarafenib confirms efficacy for solid cancer without approved treatment'
by Lee Han-soo, KBR Correspondent
2019-06-05 11:29
Seoul holds policy consultation with WHO
by Kwak Sung-sun
2019-06-04 17:35
8 out of 10 Korean doctors wish to leave the country
by Song Soo-youn
2019-06-04 15:28
[Special] Doctors skeptical about AI-based precision medicine ‘Dr. Answer’
by Kim Eun-young
2019-06-04 14:42
FDA OKs phase-1 trial for Yuhan’s investigational lung cancer drug
by Jeong Sae-im
2019-06-04 14:21
라인
‘Indoor radon exposure raises tumor mutation in lung cancer patients’
by Park Gi-taek
2019-06-04 14:19
[ASCO 2019] ‘Ontruzant demonstrates equal quality to original drug’
by Lee Han-soo, KBR correspondent
2019-06-04 14:17
‘New embolization technique can treat brain aneurysm’
by Kwak Sung-sun
2019-06-03 16:23
[ASCO 2019] ‘POLO study opens a new era for treating pancreatic cancer patients’
by Lee Han-soo, KBR corresponden
2019-06-03 16:18
Kolon’s minority shareholders demand over ₩25 billion in damage
by Jeong Sae-im
2019-06-03 14:53
-
이전
121
122
123
124
125
126
127
128
129
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top